Nuance Opens European DRIVE Lab in Germany to Amplify Innovation for Mobility Assistants
Nuance and the German Research Center for Artificial Intelligence (DFKI) will work as a joint hub for research and design […]
Foamix Announces Appointment of Matt Wiley as Chief Commercial Officer
REHOVOT, Israel, and BRIDGEWATER, N.J., Nov. 27, 2018 (GLOBE NEWSWIRE) — Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty […]
Aileron Enters Clinical Trial Collaboration with Pfizer to Evaluate ALRN-6924 in Combination with IBRANCE® (palbociclib) in MDM2-Amplified Cancers
WATERTOWN, Mass., Nov. 27, 2018 (GLOBE NEWSWIRE) — Aileron Therapeutics (NASDAQ: ALRN), the clinical-stage leader in the field of stabilized, […]
BioSig Technologies Signs Agreement with Texas Cardiac Arrhythmia Institute for First–in-Human Studies
Santa Monica, CA, Nov. 27, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical […]
Paratek Pharmaceuticals Doses First Patient in Phase 2 Clinical Trial of Omadacycline in Acute Pyelonephritis, a Common Subset of Complicated Urinary Tract Infections
BOSTON, Nov. 27, 2018 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development […]
El Pollo Loco Names Hector A. Muñoz Chief Marketing Officer
Appointment Furthers El Pollo Loco’s Commitment to Strengthening its Leadership Team COSTA MESA, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) — […]
Live Ventures Subsidiary Vintage Stock Announces Opening of New Retail Location in Time for Holiday Shopping Season
New Location is in Columbia Mall in Columbia, Missouri LAS VEGAS, Nov. 27, 2018 (GLOBE NEWSWIRE) — Live Ventures Incorporated […]
electroCore Expands Manufacturing Capabilities for gammaCore™
BASKING RIDGE, N.J., Nov. 27, 2018 (GLOBE NEWSWIRE) — electroCore, Inc. (“electroCore”) (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, today announced expansion […]
Daré Bioscience, Inc. Announces Enrollment in Thermography Feasibility Study with Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder
Sildenafil Cream, 3.6% has the Potential to Receive the First FDA Approval for Female Sexual Arousal Disorder SAN DIEGO, Nov. […]
PhaseBio Announces Dosing of First Patient in Phase 2b Clinical Trial of PB1046 in Pulmonary Arterial Hypertension
MALVERN, Pa. and SAN DIEGO, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical […]
